cancer

Celldex says Varlilumab continues to demonstrate very favorable profile
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:55 pm
Celldex Therapeutics
varlilumab
cancer
ASCO
GSK in $350 million deal to develop cancer drugs with UK biotech firm
Yahoo/Reuters
Mon, 06/2/14 - 10:02 am
GSK
R&D
cancer
UK
Adaptimmune
AstraZeneca Cancer News Boosts Soriot’s $45 Billion Case
Bloomberg
Mon, 06/2/14 - 09:27 am
AstraZeneca
Pascal Soriot
ASCO
cancer
Pfizer
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Bristol-Myers Squibb
Merck
Roche
ASCO
cancer
anti-PD-1 immunotherapy
AstraZeneca and Incyte to study cancer drugs together
Yahoo/Reuters
Wed, 05/14/14 - 08:18 am
AstraZeneca
Incyte
cancer
R&D
GlaxoSmithKline: Why Is This Pharmaceutical Giant Stepping Out Of The Cancer Arena?
Seeking Alpha
Fri, 05/9/14 - 08:11 am
GSK
cancer
Novartis
Loxo lands $24M venture round and a CSO for cancer drug research
Fierce Biotech
Wed, 05/7/14 - 08:24 am
Loxo Oncology
CSO
R&D
cancer
Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt
Bloomberg
Wed, 05/7/14 - 08:17 am
physicians
drug costs
Gilead Sciences
Sovaldi
cancer
Best Weapon In The War On Cancer? Data Sharing
Forbes
Fri, 04/25/14 - 08:18 am
data sharing
clinical trials
cancer
oncology
Project Data Sphere
AstraZeneca flags cancer advances, silent on Pfizer bid talk
Yahoo/Reuters
Thu, 04/24/14 - 11:23 am
Pfizer
AstraZeneca
M&A
cancer
earnings
Verastem: Cancer May Have Met Its Match
Seeking Alpha
Mon, 04/21/14 - 10:00 am
Verastem
cancer
stem cells
New kind of trial aims to speed cancer drug development
Yahoo/Reuters
Thu, 04/17/14 - 07:42 am
clinical trials
drug development
cancer
Pfizer
AstraZeneca
Cancer Doctors Plan to Compare Value of Expensive Drugs
Bloomberg
Wed, 04/16/14 - 05:17 pm
cancer
physicians
ASCO
Cleveland BioLabs Inc completion of Phase 1 Study of CBL0102
Reuters
Wed, 04/16/14 - 10:26 am
Cleveland BioLabs
CBL0102
cancer
This Firm's Patented Technology Could Unlock A $5 Billion Market
Yahoo/Street Authority
Sun, 04/13/14 - 10:12 am
Actinium Pharmaceuticals
cancer
Roche Will Work With Oryzon on Cancer-Suppressing Genes
Bloomberg
Mon, 04/7/14 - 08:37 am
Oryzon
Roche
cancer
epigenetics
The best-selling cancer drugs in 2013 and 2018: Roche dominates while immunotherapies, Johnson & Johnson emerge as contenders
First Word Pharma
Mon, 03/17/14 - 10:06 am
Roche
cancer
JNJ
Should Pharma Be Criticized For Investing Too Much In Fighting Cancer?
Forbes
Mon, 03/3/14 - 08:59 am
cancer
R&D
Merck & Co., Inc. Pushing The Throttle On Oncology
Motley Fool
Fri, 02/7/14 - 10:29 am
Merck
oncology
cancer
MK-3475
Celsion Provides Encouraging Post-Hoc O/S Data From HEAT Trial
Seeking Alpha
Mon, 01/27/14 - 11:52 am
Celsion
cancer
drug delivery
clinical trials

Pages